| Videos | Channels | Search |
From the Floor: Biotech surges again — #SaxoStrats (09:33)The US healthcare reform plan has pushed biotechnology shares up...
|
Quarterly outlook: Marathon bull run (04:53)The main Q4 topics for equities include the US presidential...
|
#SaxoStrats: Buying Gilead Sciences ahead of Q4... (01:45)Saxo Bank’s Head of Equity Strategy Peter Garnry is looking to buy...
|
Garnry: Four stocks I’m trading ahead of... (02:21)More than 230 companies will be reporting their quarterly earnings...
|
Berger: How I’m trading the US stock sell-off (01:29)It’s been a rough start to the year for many assets including...
|
Van-Petersen: Key currency crosses to look at... (04:14)With so many central banks meeting this week, Saxo's Kay...
|
Garnry: Why no-one is talking about the crash... (03:14)Biotechnology stocks have fallen significantly since their July...
|
Berger: Biotech ETFs bubbling higher (01:39)
The massive rally in the biotechnology sector is not over...
|
Earnings Season: GSK will disappoint but pharma... (02:29)Expect them to be disappointing. That's what Saxo's Peter Garnry...
|
Berger: NASDAQ biotechnology sector overextended (01:47)
Serge Berger, who is also known as The Steady Trader, believes...
|
#TechWeek: The NASDAQ can go even higher (02:41)The NASDAQ can go even higher says Saxo's Peter Garnry. On Monday...
|
It's Nasdaq Week - here's Peter Garnry's guide... (03:26)It's the largest US stock exchange in terms of volume and market...
|
Switch to